Table 1.
Examination of HBV serum markers in CHB, LC, and HCC patients.
| Diseases | No. | HBsAg (%) | Anti-HBs (%) | HBeAg (%) | Anti-HBe (%) | Anti-HBc (%) | HBxAg (%) | Anti-HBx (IgG) (%) |
|---|---|---|---|---|---|---|---|---|
| CHB | 173 | 172 (99.4) | 5 (2.9) | 71 (41.0) | 120 (69.3) | 173 (100) | 15 (8.7) | 18 (10.4 ) |
| LC | 106 | 86 (81.1) | 9 (8.5) | 48 (45.3) | 82 (77.4) | 105 (99.1) | 19 (17.9) | 43 (40.6)* |
| HCC | 61 | 46 (75.4) | 5 (8.2) | 17 (27.9) | 45 (73.8) | 56 (91.8) | 6 (9.8) | 21 (34.4)* |
CHB chronic hepatitis B; LC liver cirrhosis; HCC hepatocellular carcinoma. X2 test, *P < .01 (versus CHB).